Filtros : "Sanabani, S. S." Limpar

Filtros



Refine with date range


  • Source: Clinical Microbiology and Infection. Unidade: FM

    Subjects: GENÓTIPOS, VACINAS, DOENÇA CRÔNICA, LEUCEMIA MIELOIDE, COMORBIDADE, LEUCEMIA (PREVALÊNCIA), PARVOVIRIDAE (IMUNOLOGIA)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      COSTA, A. C. da et al. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities. Clinical Microbiology and Infection, v. 19, n. 1, p. E31-E43, 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/1469-0691.12058/pdf. Acesso em: 06 jun. 2024.
    • APA

      Costa, A. C. da, Bendit, I., Oliveira, A. C. S. de, Kallas, E. G., Sabino, E. C., & Sanabani, S. S. (2013). Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities. Clinical Microbiology and Infection, 19( 1), E31-E43. doi:10.1111/1469-0691.12058
    • NLM

      Costa AC da, Bendit I, Oliveira ACS de, Kallas EG, Sabino EC, Sanabani SS. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities [Internet]. Clinical Microbiology and Infection. 2013 ; 19( 1): E31-E43.[citado 2024 jun. 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/1469-0691.12058/pdf
    • Vancouver

      Costa AC da, Bendit I, Oliveira ACS de, Kallas EG, Sabino EC, Sanabani SS. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities [Internet]. Clinical Microbiology and Infection. 2013 ; 19( 1): E31-E43.[citado 2024 jun. 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/1469-0691.12058/pdf
  • Source: International Journal of STD & AIDS. Unidade: FM

    Subjects: SEQUÊNCIA DO DNA, INFECÇÕES POR HIV (TERAPIA), RETROVIRIDAE, RESISTÊNCIA MICROBIANA ÀS DROGAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KALMAR, E. M. N. et al. Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption. International Journal of STD & AIDS, v. 23, n. 2, p. 120-125, 2012Tradução . . Disponível em: http://std.sagepub.com/content/23/2/120.full.pdf+html. Acesso em: 06 jun. 2024.
    • APA

      Kalmar, E. M. N., Sanabani, S. S., Costa, A. C. da, Ferreira, S., Barreto, C. C., Chen, S., & Sabino, E. C. (2012). Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption. International Journal of STD & AIDS, 23( 2), 120-125. doi:10.1258/ijsa.2011.011124
    • NLM

      Kalmar EMN, Sanabani SS, Costa AC da, Ferreira S, Barreto CC, Chen S, Sabino EC. Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption [Internet]. International Journal of STD & AIDS. 2012 ; 23( 2): 120-125.[citado 2024 jun. 06 ] Available from: http://std.sagepub.com/content/23/2/120.full.pdf+html
    • Vancouver

      Kalmar EMN, Sanabani SS, Costa AC da, Ferreira S, Barreto CC, Chen S, Sabino EC. Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption [Internet]. International Journal of STD & AIDS. 2012 ; 23( 2): 120-125.[citado 2024 jun. 06 ] Available from: http://std.sagepub.com/content/23/2/120.full.pdf+html
  • Source: Bone marrow transplantation. Unidade: FM

    Subjects: CROMOSSOMOS, CITOGENÉTICA, TRANSPLANTES, CICLOSPORINAS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CONCHON, M. et al. Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation [Carta]. Bone marrow transplantation. Basingstoke, Hampshire: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/bmt/journal/v45/n6/pdf/bmt2009310a.pdf. Acesso em: 06 jun. 2024. , 2010
    • APA

      Conchon, M., Sanabani, S. S., Bendit, I., Serpa, M., Filho, U. A., Barros Ferreira, P. de, et al. (2010). Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation [Carta]. Bone marrow transplantation. Basingstoke, Hampshire: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/bmt/journal/v45/n6/pdf/bmt2009310a.pdf
    • NLM

      Conchon M, Sanabani SS, Bendit I, Serpa M, Filho UA, Barros Ferreira P de, Novaes MMY, Saboya R, Llacer-Dorliac PE, Dulley FL. Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation [Carta] [Internet]. Bone marrow transplantation. 2010 ; 45 1125-1126.[citado 2024 jun. 06 ] Available from: http://www.nature.com/bmt/journal/v45/n6/pdf/bmt2009310a.pdf
    • Vancouver

      Conchon M, Sanabani SS, Bendit I, Serpa M, Filho UA, Barros Ferreira P de, Novaes MMY, Saboya R, Llacer-Dorliac PE, Dulley FL. Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation [Carta] [Internet]. Bone marrow transplantation. 2010 ; 45 1125-1126.[citado 2024 jun. 06 ] Available from: http://www.nature.com/bmt/journal/v45/n6/pdf/bmt2009310a.pdf

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024